Post-translational Modification of Protein Biopharmaceuticals
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
From the leading author in the field, known around the world for his work and his authoritative publications, the contents of this book have been selected so as to reflect their relative importance for biopharmaceuticals. As a result, around half of the book is devoted to protein glycosylation, while the remainder is made up of other modifications, such as carboxylation, hydroxylation, sulfation, amidation and proteolytic processing. A final section addresses the latest trend of engineering the modification pattern to improve a given biopharmceutical, presenting several recent case studies of successful posttranslational engineering. This first authoritative overview of the topic is an indispensable guide for drug developers and drug manufacturers with an interest in protein pharmaceuticals.
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Gary Walsh is a senior lecturer in industrial biochemistry at the University of Limerick, Ireland. He combines industrial experience within the pharmaceutical industry with an extensive teaching and academic research background in pharmaceutical biotechno
- hardcover
- 440 Seiten
- Erschienen 2022
- Humana
- spiral_bound
- 240 Seiten
- Infomed Verlag
- Kartoniert
- 264 Seiten
- Erschienen 2016
- Mohr Siebeck
- hardcover
- 295 Seiten
- Erschienen 2011
- Springer
- Kartoniert
- 328 Seiten
- Erschienen 2016
- Springer
- Gebunden
- 364 Seiten
- Erschienen 2015
- V&R unipress
- paperback
- 424 Seiten
- Erschienen 2023
- Faithlife Corporation
- Kartoniert
- 73 Seiten
- Erschienen 2020
- Waxmann
- Gebunden
- 570 Seiten
- Erschienen 2008
- Springer
- Kartoniert
- 299 Seiten
- Erschienen 2009
- Junfermann Verlag
- hardcover
- 496 Seiten
- Erschienen 2008
- De Gruyter
- Kartoniert
- 261 Seiten
- Erschienen 2017
- Nomos




